Connor Page
patientMale0.0Global Dominance: 0.00%
Connor Page was a 39-year-old father diagnosed with pancreatic cancer in 2022, whose participation in a clinical trial for the drug daraxonrasib provided him with several months of improved health and valuable time with his family before his passing in 2024.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Connor Page learned he had pancreatic cancer in 2022 and participated in a Phase 1 trial.
Drug that could extend lives of Canadians with pancreatic cancer remains out of reach for patientsThe Globe and Mail·
Canada· 2026-07-08
Canada· 2026-07-08
